Key result
Treat-to-target titration algorithms optimize insulin initiation and glycemic control in diabetes management.
Answers are grounded in this paper and cite their sources.
Reviews treat-to-target trial designs in diabetes management, highlighting their role in optimizing insulin titration algorithms and individualizing glycemic control.
Treat-to-target is a therapeutic concept that considers well defined and specific physiologic targets as aims in controlling the pathophysiology of the disease. It has been widely used in diseases that pathophysiology includes, chronic metabolic and physiological disturbances, namely rheumatic conditions, vascular medicine and diabetes. In diabetes, the availability of "gold-standard" quantitative measures like fasting plasma glucose and glycated hemoglobin make the application of treat-to-target trials especially pertinent. Treatment modalities which have used single therapeutic agents or combinations or in combination with a variety of titration algorithms and implementation protocols have broadened our understanding of diabetes management with specific reference to insulin initiation and maintenance. Treat-to-target trials have been used to investigate a wide variety of questions including efficacy, safety, effect of treatment on comorbidities and patient satisfaction, ideal mechanisms to implement insulin initiation etc. A more generalized acceptance and implementation of treat-to-target trials may finally revolutionize diabetes management by combining aspects of individual care with standard treatment protocols.
No takes yet. Share an insight, caveat, or question.
Wangnoo et al. (2014) conducted a review in Diabetes. Treat-to-target therapeutic strategy was evaluated. Treat-to-target trial designs using titration algorithms and glycemic targets like HbA1c and fasting plasma glucose help optimize insulin initiation and maintenance in diabetes management.
Synapse has enriched 10 related papers. Consider them for comparative context: